Molecular Vision: Cheung, Mol Vis 2012; 18:830-837. Table 2

Table 2. Summary of cytokine level in all measured aqueous humor.

	DR n=27		No-DR n=20		Control n=24		p-value
Cytokines	Median^a	Range^b	Median^a	Range^b	Median^a	Range^b	DR Control	No-DR Control	DR-No-DR
IL-2	0.0*	0–3	0.0†	0–2	2.1	0–17	0.001	0.003	1.000
IL-13	2.2	0–75	0.6	0–11	2.8	0–8	1.000	1.000	0.981
IL-6	16.4*	0–1988	1.9	0–53	2.2	0–28	0.048	1.000	0.544
IL-10	0.0*	0–7	0.0†	0–1	1.3	0–3	0.003	0.004	1.000
IL-12	0.0*	0–2	0.0†	0–5	6.8	0–18	<0.001	0.001	1.000
TNF-α	0.0*	0–1	0.0†	0–4	7.6	0–15	0.002	0.019	1.000
IL-1Rα	76.5	0–185	9.3	8–414	8.6	3–96	0.414	0.634	1.000
IFN-α	0.0*	0–18	0.0†	0–20	26.2	0–84	0.008	0.012	1.000
CCL2	386.5*	21–1537	267.6	3–1863	193.1	76–816	0.030	0.645	1.000
CCL4	21.1	8–437	25.1	1–150	17.4	4–72	1.000	1.000	1.000
CXCL8	8.3	0–106	6.3	0–63	3	0–48	0.052	1.000	1.000
CXCL9	0	0–3243	0	0–493	89.5	0–1173	1.000	0.168	1.000
CXCL10	348.5	0–12055	104.7	0–1612	71.5	0–2571	1.000	1.000	1.000
IL-7	4.3	0–79	3.4	0–45	1.1	0–15	0.684	0.264	1.000
GM-CSF	0.0	0–309	0.0	0–416	125.4	0–562	0.071	0.824	1.000
VEGF	1587.3*	119–3375	781.0†	43–1287	39.8	25–81	<0.001	0.002	0.117

DR=Diabetic with retinopathy; No-DR=Diabetic with no retinopathy; IL=Interleukin; IFN=Interferon; TNF=Tumor necrosis factor; GM-CSF=Granulocyte-macrophage colony-stimulating factor; VEGF=Vascular endothelial growth factor. Significant difference is accepted at p<0.05. a Median of measured samples (pg/ml); b Range of measured samples (pg/ml); c p-value calculated using Mann–Whitney U with Bonferroni correction comparing two groups; * p<0.05, DR versus Control; † p<0.05, No-DR versus Control